Pfizer Inc. said it notified Pain Therapeutics that it is ending its agreement to develop and commercialize an investigational extended-release version of oxycodone.
from WSJ.com: US Business http://ift.tt/1txPBfQ
via IFTTT
from WSJ.com: US Business http://ift.tt/1txPBfQ
via IFTTT
No comments:
Post a Comment